Skip to main content

Month: December 2020

Patriot Reports Minimal Net Loss of $87 thousand ($.02 per share) for third quarter 2020 – Loan Loss Provisions lowered; Net Interest and Non-interest Income Improve

STAMFORD, Conn., Dec. 01, 2020 (GLOBE NEWSWIRE) — Patriot National Bancorp, Inc. (“Patriot,” “Bancorp” or the “Company”) (NASDAQ: PNBK), the parent company of Patriot Bank, N.A. (the “Bank”), today announced a net loss of $87,000, or $0.02 basic and diluted loss per share for the quarter ended September 30, 2020, compared with a net loss of $1.3 million reported in the second quarter of 2020. The improvement compared with the second quarter of 2020 resulted from a lower provision for loan losses and higher net interest and non-interest income.The net loss for the nine-month period ended September 30, 2020 was $2.4 million, or $0.62 per fully diluted share, as compared to a net loss of $1.3 million, or $0.33 per fully diluted shares, during the same period in the prior year. The 2020 results to date, reflect lower net interest income...

Continue reading

Aftale om Market Making opsagt

LEI-Kode: 213800BGF1TQB5M6PH65Selskabsmeddelelse nr. 10/2020Aftale om Market Making opsagt.Arbejdernes Landsbank har siden den 2. januar 2018 været Liquidity Provider i Møns Bankaktier, fondskode ISIN nr. DK.0060133841 på Nasdaq Copenhagen A/S.Møns Bank har opsagt aftalen med virkning fra og med ultimo året 2020.Eventuelle spørgsmål til denne meddelelse kan rettes til undertegnede.Med venlig hilsenMøns BankFlemming Jul JensenBankdirektørVedhæftet filAftale om Market Making opsagt

Continue reading

BALTIC HORIZON FONDI 2020. AASTA III KVARTALI KONSOLIDEERITUD AUDITEERIMATA MAJANDUSTULEMUSED

Northern Horizon Capital AS-i juhatus on kinnitanud Baltic Horizon Fondi (Fond) auditeerimata konsolideeritud vahearuande tulemused 2020. aasta III kvartali kohta.COVID-19 pandeemia mõju2020. aasta alguses hakkas kõikjal maailmas levima uus koroonaviirus (COVID-19), mis on mõjutanud erinevate riikide, sh Balti riikide, ettevõtteid ja majandust. Viiruse levik on muutnud oluliselt Fondi tegevuskeskkonda, millel on negatiivne mõju Fondi 2020. aasta majandustulemustele. Praegu saadaoleva informatsiooni alusel usub Fondivalitseja siiski, et COVID-19 pandeemia avaldab Fondi tulemustele pigem ajutist mõju. Hästi hajutatud portfell peaks võimaldama Fondil COVID-19 mõju piirata ja jätkuvalt korralikke konsolideeritud majandustulemusi saavutada.Oma finantsseisundi tugevdamiseks on Fond otsustanud jätta ligikaudu 2,2 miljoni euro ulatuses 2020....

Continue reading

SunHydrogen Announces $9.0 Million Registered Direct Offering

SANTA BARBARA, CA, Dec. 01, 2020 (GLOBE NEWSWIRE) — SunHydrogen, Inc. (OTC: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 120,000,000 shares of its common stock and short-term warrants to purchase an aggregate of up to 120,000,000 shares of common stock, in a registered direct offering. The combined purchase price for one share of common stock and a warrant to purchase one share of common stock is $0.075. The warrants have an exercise price of $0.075 per share, will be immediately exercisable and will expire 30 months from the issue date.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The gross proceeds from the...

Continue reading

Atlas Technical Consultants Completes Acquisition of WesTest

AUSTIN, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading provider of professional testing, inspection, environmental, engineering, program management and consulting services, announced today that it closed on its previously announced acquisition of WesTest LLC (“WesTest”), a key provider of transportation-related testing and inspection services. Headquartered in Lakewood, Colorado, WesTest provides a wide range of materials testing, specification development, forensic engineering, geotechnical engineering and construction support services in Colorado.L. Joe Boyer, Atlas’ Chief Executive Officer, said, “We are extremely pleased to welcome the employees and clients of WesTest to the Atlas family. Their team brings a well-respected brand, technical expertise...

Continue reading

Broadcom Unveils the Industry’s First Open AIOps Platform Delivering a New Level of Full-Stack Observability for Hybrid Clouds

SAN JOSE, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ:AVGO) today announced the availability of the latest generation of AIOps from Broadcom, an open platform with artificial intelligence, machine learning and end-to-end observability that helps organizations achieve operational excellence. AIOps allows business and IT leaders to manage critical KPIs that align IT outputs to business outcomes, driving digital agility, while proactively ensuring enhanced customer and positive employee experiences.“Imagine a lens that provides a clear and fully integrated view of your business with IT providing valuable intelligence that drives informed decision-making. This is no longer a wish list, this is a reality for our customers through the new Broadcom AIOps solution,” said Serge Lucio, vice president and general manager,...

Continue reading

SSE Enterprise Telecoms Expands High-capacity Fiber Network with Infinera, Enabling 5G Across the UK

SUNNYVALE, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today that SSE Enterprise Telecoms, one of the UK’s leading connectivity providers, has selected Infinera’s XTM Series for the second phase of its UK-wide network expansion. The expanded network will bring high-capacity services to more businesses across the UK, further facilitating 5G rollouts, and aiding in the deployment of next-generation connectivity technologies such as the Industrial Internet of Things (IIoT).With Infinera’s XTM Series, SSE Enterprise Telecoms leverages an industry-leading optical solution optimized for 5G transport with high-performance synchronization capabilities and low latency. The network’s Layer 2 packet optical aggregation features also provide enterprise customers with high-bandwidth connectivity services over the...

Continue reading

Minerva Neurosciences Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Roluperidone

WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it has received official meeting minutes from the November 10, 2020 Type C meeting with the U.S. Food and Drug Administration (FDA) regarding development of roluperidone for treatment of negative symptoms in schizophrenia.The objective of this meeting was to obtain FDA input regarding the roluperidone data package and its readiness to support a New Drug Application (NDA) submission. The two main topics addressed during the meeting were:1.   Readiness for submission of NDAMinerva requested confirmation from FDA that, based on the totality of evidence, the data from the MIN-101C03 (Phase 2b)...

Continue reading

Cidara Therapeutics to Present Preclinical Data for Influenza AVCs at the 7th ESWI Influenza Conference

SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced a keynote lecture, an oral presentation and two posters at the 7th European Scientific Working Group on Influenza (ESWI) Influenza Conference, which takes place virtually Dec. 6-9, 2020.The Keynote Lecture highlights Cidara’s Cloudbreak antiviral platform, specifically its program for universal protection from influenza. Details of the Keynote Lecture are as follows:The oral and poster presentations highlight preclinical data from the antiviral conjugate (AVC) candidate, CD377 for prevention and treatment of influenza. Details of the presentations are as follows:The Keynote...

Continue reading

Alex Cunningham, Cardiff Lexington CEO, is Featured in a New Audio Interview with SmallCapVoice.com

AUSTIN, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (“SCV”) today announced the availability of a recent interview with the leadership of Cardiff Lexington Corporation (OTC PINK:CDIX) (the “Company”), a holding company that has four operating subsidiaries with businesses in the financial services and real estate industries. The interview outlines the development of CDIX’s portfolio of subsidiary companies, the evolution of the Company to date, and the goals for the remainder of 2020 and beyond.Speaking with SCV’s Stuart Smith, Cunningham explains the genesis and story behind the recent moves by CDIX and the foundation built in previous years through accomplishments in 2020. In 2020, amidst a global pandemic, the Company was able to make key strategic moves fortifying CDIX for future growth and expansion. CDIX’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.